This ongoing column explores off-label or emerging treatment options, drug development trends, and theoretical concepts in the field of neuroscience. by Rajashekar Reddy Yeruva, MD; Hema Madhuri Mekala, MD; Priyanga
This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by
by Brian Chau, MD; Ivan Phelan, MS; Phillip Ta, MD; Sarah Humbert, MD; Justin Hata, MD; and Duc Tran, MD, PhD Dr. Chau, Dr. Ta, Dr. Humbert, Dr. Hata, and
by Shahid Ali, MD; Barira Tahir, MD; Shagufta Jabeen, MD; and Madeeha Malik Drs. Ali and Tahir are with the Smart Choice Treatment Center in Franklin, Tennessee. Ms. Malik is
by Anoop K. Gupta, MBBS; Swapnajeet Sahoo, MD; and Sandeep Grover, MD Dr. Gupta is a junior resident, Dr. Sahoo is a senior resident, and Dr. Grover is a professor
by Karim Yahia Jaffer; Tiffany Chang; Brigitte Vanle, PhD; Jonathan Dang, MD; Alexander J. Steiner, PsyD; Natalie Loera, BA; Marina Abdelmesseh, MD; Itai Danovitch, MD; and Waguih William IsHak, MD,
